4.92
price down icon1.20%   -0.06
 
loading
Schlusskurs vom Vortag:
$4.98
Offen:
$4.99
24-Stunden-Volumen:
33,615
Relative Volume:
0.16
Marktkapitalisierung:
$11.13M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-58.52M
KGV:
-2.3541
EPS:
-2.09
Netto-Cashflow:
$-45.03M
1W Leistung:
+3.36%
1M Leistung:
+946.81%
6M Leistung:
+517.70%
1J Leistung:
+201.84%
1-Tages-Spanne:
Value
$4.92
$5.2265
1-Wochen-Bereich:
Value
$4.78
$5.37
52-Wochen-Spanne:
Value
$0.224
$5.37

Nextcure Inc Stock (NXTC) Company Profile

Name
Firmenname
Nextcure Inc
Name
Telefon
240-399-4900
Name
Adresse
9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD
Name
Mitarbeiter
43
Name
Twitter
@nextcureinc
Name
Nächster Verdiensttermin
2025-03-07
Name
Neueste SEC-Einreichungen
Name
NXTC's Discussions on Twitter

Vergleichen Sie NXTC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
NXTC
Nextcure Inc
4.92 11.13M 0 -58.52M -45.03M -2.09
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Nextcure Inc Stock (NXTC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-11-04 Herabstufung Ladenburg Thalmann Buy → Neutral
2022-03-01 Eingeleitet Ladenburg Thalmann Buy
2021-03-05 Hochstufung Truist Hold → Buy
2021-01-15 Herabstufung BofA Securities Neutral → Underperform
2020-07-16 Hochstufung The Benchmark Company Hold → Buy
2020-07-13 Herabstufung ROTH Capital Buy → Neutral
2020-07-13 Herabstufung SunTrust Buy → Hold
2020-06-01 Herabstufung BofA/Merrill Buy → Neutral
2020-06-01 Herabstufung The Benchmark Company Buy → Hold
2020-05-26 Eingeleitet JMP Securities Mkt Outperform
2020-03-24 Eingeleitet The Benchmark Company Buy
2020-03-02 Eingeleitet ROTH Capital Buy
2020-01-13 Eingeleitet SunTrust Buy
2019-12-05 Eingeleitet Needham Buy
2019-11-26 Eingeleitet BTIG Research Buy
2019-07-09 Eingeleitet BofA/Merrill Buy
2019-06-03 Eingeleitet Morgan Stanley Overweight
2019-06-03 Eingeleitet Piper Jaffray Overweight
Alle ansehen

Nextcure Inc Aktie (NXTC) Neueste Nachrichten

pulisher
04:50 AM

What analysts say about NextCure Inc. stockTriple-digit wealth increases - Autocar Professional

04:50 AM
pulisher
Jul 22, 2025

NextCure Inc. Stock Analysis and ForecastMarket-beating returns - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

What drives NextCure Inc. stock priceExceptional return forecasts - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Is NextCure Inc. a good long term investmentHigh-octane financial growth - Autocar Professional

Jul 21, 2025
pulisher
Jul 16, 2025

What makes NextCure Inc. stock price move sharplyConsistent Growth Alert - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

Why NextCure Inc. stock attracts strong analyst attentionFree Access to Community - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

How NextCure Inc. stock performs during market volatilitySecure Your Capital Strategy - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Piper Sandler lowers NextCure stock price target to $15 after reverse split By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 15, 2025

Piper Sandler lowers NextCure stock price target to $15 after reverse split - Investing.com India

Jul 15, 2025
pulisher
Jul 14, 2025

NextCure initiates one-for-twelve reverse stock split on Nasdaq By Investing.com - Investing.com Nigeria

Jul 14, 2025
pulisher
Jul 14, 2025

NextCure Implements Reverse Stock Split on Nasdaq - TipRanks

Jul 14, 2025
pulisher
Jul 14, 2025

NextCure initiates one-for-twelve reverse stock split on Nasdaq - Investing.com

Jul 14, 2025
pulisher
Jul 10, 2025

NextCure Announces One-for-Twelve Reverse Stock Split - TipRanks

Jul 10, 2025
pulisher
Jul 10, 2025

NextCure announces 1-for-12 reverse stock split effective July 14 - Investing.com Nigeria

Jul 10, 2025
pulisher
Jul 10, 2025

NextCure announces 1-for-12 reverse stock split effective July 14 By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 06, 2025

Analysts Offer Insights on Healthcare Companies: NextCure (NXTC), Lexaria Bioscience (LEXX) and Travere Therapeutics (TVTX) - The Globe and Mail

Jul 06, 2025
pulisher
Jul 02, 2025

NextCure’s (NXTC) Buy Rating Reaffirmed at HC Wainwright - Defense World

Jul 02, 2025
pulisher
Jun 23, 2025

Eyes on Asia: AstraZeneca, NextCure, Sagimet Biosciences - BioXconomy

Jun 23, 2025
pulisher
Jun 17, 2025

Nextcure Inc: Analyzing NXTC Stock Trends - investchronicle.com

Jun 17, 2025
pulisher
Jun 17, 2025

Market Recap: Next Technology Holding Inc (NXTT)’s Positive Momentum, Closing at 1.40 - DWinneX

Jun 17, 2025
pulisher
Jun 17, 2025

Market Highlights: Nextcure Inc (NXTC) Ends on a Low Note at 0.50 - DWinneX

Jun 17, 2025
pulisher
Jun 17, 2025

NextCure tanks as it teams up with Simcere on novel ADC - The Pharma Letter

Jun 17, 2025
pulisher
Jun 17, 2025

NextCure and Simcere partner to develop SIM0505 for solid tumours - Yahoo Home

Jun 17, 2025
pulisher
Jun 16, 2025

NextCure partners with Simcere Zaiming on cancer drug development By Investing.com - Investing.com South Africa

Jun 16, 2025
pulisher
Jun 16, 2025

NextCure Joins China-ADC Gold Rush with $745M Simcere Deal - BioSpace

Jun 16, 2025
pulisher
Jun 16, 2025

NextCure Inks $745M Deal With Simcere For Cancer Drug: Retail’s More Optimistic Despite Stock’s 27% Decline - Asianet Newsable

Jun 16, 2025
pulisher
Jun 16, 2025

NextCure And Simcere Zaiming Partner To Develop CDH6-Targeting ADC SIM0505 For Solid Tumors - Nasdaq

Jun 16, 2025
pulisher
Jun 16, 2025

NextCure signs up to $745 million deal with China's Simcere to develop cancer drug - MarketScreener

Jun 16, 2025
pulisher
Jun 16, 2025

Simcere Pharmaceutical's Unit Enters Into License Agreement With Nextcure - marketscreener.com

Jun 16, 2025
pulisher
Jun 16, 2025

NextCure Enters Licensing Agreement with Simcere Zaiming - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

NextCure (NXTC) Partners with Simcere Zaiming for Innovative Cancer Treatment | NXTC Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

NextCure partners with Simcere Zaiming on cancer drug development - Investing.com Australia

Jun 16, 2025
pulisher
Jun 16, 2025

Nextcure And Simcere Zaiming Announce Strategic Partnership For A Novel Antibody-Drug Conjugate Targeting CDH6 - marketscreener.com

Jun 16, 2025

Finanzdaten der Nextcure Inc-Aktie (NXTC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):